Table VI.
Group | PTEN | mTOR | Topo II |
---|---|---|---|
Blank | 1 | 1 | 1 |
Control | 1.62±0.23a | 0.93±0.12 | 0.62±0.19a |
Treatment | 2.17±0.34a | 0.33±0.11a | 1.74±0.18a |
n=3
P<0.05 vs. blank group. Data are expressed as the mean ± standard deviation. DNR, daunorubicin; mTOR, mechanistic target of rapamycin; PTEN, phosphatase and tensin homolog; Topo II, topoisomerase II; YQYYT; yi-qi-yang-yin-tang.